
JAK Inhibitors in Rheumatoid Arthritis: Overcoming Challenges and Maximizing Impact
12/11/2025
0:00
38:19
See where Janus kinase (JAK) inhibitors fit into rheumatoid arthritis (RA) treatment to tackle obstacles and improve patient outcomes.
Credit available for this activity expires: 12/10/2026
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[articleID]?ecd=bdc_podcast_libsyn_mscpedu
More episodes from "Keeping Current CME"



Don't miss an episode of “Keeping Current CME” and subscribe to it in the GetPodcast app.







